Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05829681 · ClinicalTrials.gov registry record · NA

Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCD

A NA study of Obsessive - Compulsive Disorder, sponsored by Stanford University.

Active
Registry status
NA
Development phase
212
Enrollment target
1
Study location

NCT05829681 is a NA study of Obsessive - Compulsive Disorder that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 212 participants, below the 2,062-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05829681, a NA study of Obsessive - Compulsive Disorder, is active but no longer recruiting, sponsored by Stanford University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
212 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to discover brain-based subtypes of Obsessive Compulsive Disorder (OCD) and examine treatment response to two different repetitive transcranial magnetic stimulation (rTMS) targets in the brain: the medial prefrontal cortex (MPFC) and the right prefrontal cortex (rPFC).

Interventions

  • DEVICE Repetitive Transcranial Magnetic Stimulation

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 212 participants
Start Date 2022-03-14
Est. Completion 2029-03-14
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05829681

The ClinicalTrials.gov registry entry for NCT05829681 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,062-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (90% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Repetitive Transcranial Magnetic Stimulation is the first listed.

NCT05829681 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05829681 about?

NCT05829681 is a clinical study titled "Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCD". The goal of this clinical trial is to discover brain-based subtypes of Obsessive Compulsive Disorder (OCD) and examine treatment response to two different repetitive transcranial magnetic stimulation (rTMS) targets in the brain: the medial prefrontal cortex (MPFC) and the right prefrontal cortex (rP...

What is the current status of trial NCT05829681?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 212 participants. The study started on 2022-03-14. Estimated completion is 2029-03-14.

What conditions does trial NCT05829681 study?

This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT05829681?

The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05829681?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05829681 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obsessive - Compulsive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.